Background: Boston From Across The Charles River

Productivity through Innovation

Fraunhofer CMI - Center for Manufacturing Innovation

Four Project Slideshow - Animated GIF
Adobe Flash Player is required for optimal slideshow performance.
If the problem persists, try using this bypass detection link.
© 2015 Fraunhofer CMI.

The Fraunhofer Center for Manufacturing Innovation (CMI) conducts advanced research and development and engineers solutions for a broad range of industries, including biotechnology, photonics, manufacturing, and renewable energy. Engineers, scientists, faculty, and students at our Center transform emerging research into viable technology solutions that meet the needs of both domestic and global clients. Our services include product and device development, high precision automation systems, and laboratory assays & instruments.

Spotlight

Fraunhofer CMI AST

Fraunhofer CMI addresses the president's national action plan to combat antimicrobial resistance

The rise of bacterial resistance intensifies the need for rapid phenotype-based antibiotic susceptibility tests (ASTs) in order to safeguard our drugs of last resort. Standard ASTs are based on bacterial growth inhibition in the presence of antibiotics that take multiple (8-24) hours to complete.

Continue reading »

Image of Viable endothelial cells in a Fraunhofer CMI bioprinted ring 24h post-printing

Fraunhofer CMI has developed a 3D Bioprinting System for the next Generation of "Bottom-Up" Tissue Engineering

The list of patients in dire need of organ transplants grows longer every day. Patients who are fortunate enough to find a 'match' still struggle with immunosuppressive therapy and ultimate organ failure. The goal of 3D bio printing is to precisely place cells in environments that trigger...

Continue reading »

Preview Image of Artificial Hand

Fraunhofer CMI Developed Artificial Hand for Minimally Invasive Surgery

Over the past several decades, minimally invasive surgery has become more prevalent because it does not require major incisions to the patient, allows for quicker healing, reduces post-operative pain, and may reduce wound complications. However, in comparison to open surgery, existing laparoscopic tools still limit the surgeon's dexterity significantly.

Continue reading »

Preview Image of Artificial Hand

Plant-Based Vaccine Production

Fraunhofer CMI, in collaboration with the Fraunhofer Center for Molecular Biotechnology (CMB) and Boston University, has developed an automatic, scalable, natural plant "factory" that can efficiently produce large quantities of medication to address potential biological threats. Located in Newark, Delaware, the facility officially became operational in April 2010...

Continue reading »